Opinions of Community Pharmacists About Collaboration with General Practitioners: A Descriptive Pilot Study After New Legislation in Turkey

Journal Title: Turkish Journal of Pharmaceutical Sciences - Year 2018, Vol 15, Issue 2

Abstract

Objectives: Committed legal regulations in primary healthcare services have resulted in certain issues and requirements about community pharmacy practices in Turkey. A professional collaboration between general practitioners and pharmacists is essential for the continuity of care in primary care settings. Therefore, the aim of this was study to explore community pharmacists’ opinions on collaborative care along with new primary care regulations. Materials and Methods: A web-based questionnaire was implemented during a period of five months to a voluntary sample of community pharmacists. The questionnaire consisted of multiple-choice questions that allowed participants to select more than one answer wherever appropriate. Results: One hundred ninety-seven community pharmacists responded to the questionnaire; 66% were younger than 39 years and had less than 15 years’ experience in the profession. In general, the pharmacists are willing to be involved in maintaining continuity of care, especially in patient counselling. However, 10.7% of participants indicated that the main reasons for not being actively involved in patient care were ‘mainly dealing with explaining prescription co-payment procedures’ and ‘having unfavorable attitudes of other healthcare professionals’. They believed that their contributions were restricted by laws and regulations (14.2%) as well as declined perceived reputation (53.8%) of the profession among the public. Conclusion: Revealing misperceptions among patients and healthcare professionals, overcoming limitations of current practice and an understanding of each profession’s responsibilities may lead to formation of a new and more effective model of care.

Authors and Affiliations

Aygin BAYRAKTAR EKİNCİOĞLU, Kutay DEMİRKAN

Keywords

Related Articles

Investigation of the Antioxidant, α-Glucosidase Inhibitory, Anti-inflammatory, and DNA Protective Properties of Vaccinium arctostaphylos L.

Objectives: The scope of this study was to investigate the total phenolic, anthocyanin, and flavonoid contents and the biological properties of ethanol extract (EE), methanol extract (ME), and aqueous extract (AE) from V...

A Validated Reverse Phase-Ultra-Performance Liquid Chromatography Method for the Determination of Gemifloxacin Mesylate in Bulk and its Pharmaceutical Preparation

Objectives: Gemifloxacin Mesylate is a fourth generation fluoroquinolone antibacterial agent. A simple, accurate, and precise reversed phase (RP)- ultra performance liquid chromatography (UPLC) method was developed and v...

Simultaneous Determination of Arbutin and Hydroquinone in Different Herbal Slimming Products Using Gas Chromatography-mass Spectrometry

Objectives: The aim of our study was to develop a simple, precise, sensitive and specific method for the simultaneous determination of arbutin and hydroquinone in different herbal slimming products using GC-MS. Materials...

In Vitro Macrophage Nitric Oxide and Interleukin-1 Beta Suppression by Moringa peregrina Seed

Objectives: Moringa peregrina has long been used in folk medicine to treat diseases including fever, headache, burns, constipation, gut pains, and inflammation. Nitric oxide (NO) and interleukin-1β (IL-1β) play an import...

Some New Hydrazone Derivatives Bearing the 1,2,4-Triazole Moiety as Potential Antimycobacterial Agents

Objectives: The aim of this study was to synthesize, characterize, and screen some new 1-(4-((2-(4-substitutedphenyl)hydrazono)methyl)phenyl)-1H-1,2,4-triazole derivatives for their antimycobacterial activities. Material...

Download PDF file
  • EP ID EP382453
  • DOI 10.4274/tjps.55376
  • Views 112
  • Downloads 0

How To Cite

Aygin BAYRAKTAR EKİNCİOĞLU, Kutay DEMİRKAN (2018). Opinions of Community Pharmacists About Collaboration with General Practitioners: A Descriptive Pilot Study After New Legislation in Turkey. Turkish Journal of Pharmaceutical Sciences, 15(2), 212-218. https://europub.co.uk/articles/-A-382453